First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent-Reference-Cited by-同舟云学术

First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent

Published:2015-11-18 Issue:11 Volume:10 Page:e0143082
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Allen Joshua E.,Crowder Roslyn,El-Deiry Wafik S.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference17 articles.

1. Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects;JE Allen;Science translational medicine,2013

2. Following TRAIL's path in the immune system;C Falschlehner;Immunology,2009

3. Regulation of the human TRAIL gene;JE Allen;Cancer biology & therapy,2012

4. Treating the treatment: toxicity of cancer chemotherapy;IH Plenderleith;Canadian family physician Medecin de famille canadien,1990

5. Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms;S Liu;Cancer treatment reviews,2014

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mitochondrial protease ClpP is a druggable target that controls VSMC phenotype by a SIRT1-dependent mechanism;Redox Biology;2024-07

2. Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma;Neuro-Oncology;2024-04-01

3. Nivolumab plus ONC201 plus in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) patients: a Brown University Oncology Research Group phase Ib/II study (BrUOG379);Translational Gastroenterology and Hepatology;2024-04

4. Trials and Tribulations of MicroRNA Therapeutics;International Journal of Molecular Sciences;2024-01-25

5. Quinoxalinone substituted pyrrolizine (4h)-induced dual inhibition of AKT and ERK instigates apoptosis in breast and colorectal cancer by modulating mitochondrial membrane potential;European Journal of Pharmacology;2023-10